Forge Biologics Archives - Page 3 of 4 - Forge Biologics

FDA Fast Track, ODD, and RPDD Designations for FBX-101 Gene Therapy for Patients with Krabbe Disease

FDA Clearance of Investigational New Drug for Patients with Krabbe Disease

United Leukodystrophy Foundation

VIDEO: Manufacturing Capabilities

“Building Better” Blog: Forge Biologics Spotlight

RESKUE Trial for Patients with Krabbe Disease

Announcing: Blaze Vector™ Production

FDA Clearance of Investigational New Drug for Patients with Krabbe Disease

David Dismuke, Ph.D.

Our Gene Therapy Players: The Starting Lineup

I agree to the Cookie Notice and Privacy Policy

I agree